Metabolic and vascular effects of the thiazolidinedione troglitazone

Diabetes Reviews

Volumn 7, Issue 2, 1999, Pages 55-76

  Saleh, Y M ^a   Mudaliar, S R ^a   Henry, R R ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; INSULIN; ORAL ANTIDIABETIC AGENT; TROGLITAZONE;

ADIPOSE TISSUE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DRUG RECEPTOR BINDING; DYSLIPIDEMIA; GENE EXPRESSION REGULATION; GLUCONEOGENESIS; GLUCOSE METABOLISM; HYPERCOAGULABILITY; HYPERGLYCEMIA; HYPERINSULINEMIA; HYPERTENSION; INSULIN RELEASE; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE;

EID: 0032779907     PISSN: 10669442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (101)